The tetraspanin CD82 is specifically recruited to fungal and bacterial phagosomes prior to acidification

Infection and Immunity

Volumn 79, Issue 3, 2011, Pages 1098-1106

  Artavanis Tsakonas, Katerina ^a   Kasperkovitz, Pia V ^b   Papa, Eliseo ^a   Cardenas, Michael L ^b   Khan, Nida S ^b   Van Der Veen, Annemarthe G ^a   Ploegh, Hidde L ^a   Vyas, Jatin M ^b  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD63 ANTIGEN; CD82 ANTIGEN; HYBRID PROTEIN; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; POLYSTYRENE; RED FLUORESCENT PROTEIN; TETRASPANIN; TOLL LIKE RECEPTOR;

ACIDIFICATION; ANIMAL CELL; ARTICLE; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; CRYPTOCOCCUS NEOFORMANS; DENDRITIC CELL; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; ESCHERICHIA COLI; HUMAN; MOUSE; NONHUMAN; PHAGOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTIGEN-PRESENTING CELLS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FLUORESCENT ANTIBODY TECHNIQUE; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; KANGAI-1 PROTEIN; MICE; MICROSCOPY, CONFOCAL; PHAGOSOMES; PROTEIN TRANSPORT; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 79952303272     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01135-10     Document Type: Article

References (46)

1. Alvarez, M., and A. Casadevall. 2006. Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages. Curr. Biol. 16:2161-2165.
2. Artavanis-Tsakonas, K., J. C. Love, H. L. Ploegh, and J. M. Vyas. 2006. Recruitment of CD63 to Cryptococcus neoformans phagosomes requires acidification. Proc. Natl. Acad. Sci. U. S. A. 103:15945-15950.
3. Bandyopadhyay, S., et al. 2006. Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression. Nat. Med. 12:933-938.
4. Blander, J. M., and R. Medzhitov. 2006. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440:808-812.
5. Boes, M., et al. 2002. T-cell engagement of dendritic cells rapidly rearranges MHC class II transport. Nature 418:983-988. (Pubitemid 34976034)
6. Braun, V., et al. 2004. TI-VAMP/VAMP7 is required for optimal phagocytosis of opsonised particles in macrophages. EMBO J. 23:4166-4176. (Pubitemid 39546155)
7. Chairoungdua, A., D. L. Smith, P. Pochard, M. Hull, and M. J. Caplan. 2010. Exosome release of {beta}-catenin: a novel mechanism that antagonizes Wnt signaling. J. Cell Biol. 190:1079-1091.
8. Danglot, L., et al. 2010. Role of TI-VAMP and CD82 in EGFR cell-surface dynamics and signaling. J. Cell Sci. 123:723-735.
9. De Jesus, M., et al. 2009. Galactoxylomannan-mediated immunological paralysis results from specific B cell depletion in the context of widespread immune system damage. J. Immunol. 183:3885-3894.
10. Engering, A., and J. Pieters. 2001. Association of distinct tetraspanins with MHC class II molecules at different subcellular locations in human immature dendritic cells. Int. Immunol. 13:127-134.
11. Escola, J. M., et al. 1998. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J. Biol. Chem. 273:20121-20127.
12. Fedor Berditchevski, E. O. 2007. Tetraspanins as regulators of protein trafficking. Traffic 8:89-96.
13. Garcia-Rivera, J., Y. C. Chang, K. J. Kwon-Chung, and A. Casadevall. 2004. Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan. Eukaryot. Cell 3:385-392. (Pubitemid 38497977)
14. Hammond, C., et al. 1998. The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, -DM, and -DO molecules. J. Immunol. 161:3282-3291.
15. Hemler, M. E. 2008. Targeting of tetraspanin proteins - potential benefits and strategies. Nat. Rev. Drug Discov. 7:747-758.
16. Hemler, M. E. 2003. Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu. Rev. Cell Dev. Biol. 19:397-422.
17. Husebye, H., et al. 2006. Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity. EMBO J. 25:683-692. (Pubitemid 43292431)
18. Kasperkovitz, P. V., M. L. Cardenas, and J. M. Vyas. 2010. TLR9 is actively recruited to Aspergillus fumigatus phagosomes and requires the N-terminal proteolytic cleavage domain for proper intracellular trafficking. J. Immunol. 185:7614-7622.
19. Kitchens, R. L., P. Wang, and R. S. Munford. 1998. Bacterial lipopolysaccharide can enter monocytes via two CD14-dependent pathways. J. Immunol. 161:5534-5545.
20. Kropshofer, H., et al. 2002. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes. Nat. Immunol. 3:61-68.
21. Latge, J. P. 2010. Tasting the fungal cell wall. Cell Microbiol. 12:863-872.
22. Lazo, P. A. 2007. Functional implications of tetraspanin proteins in cancer biology. Cancer Sci. 98:1666-1677. (Pubitemid 47487899)
23. Levy, S., and T. Shoham. 2005. The tetraspanin web modulates immune-signalling complexes. Nat. Rev. Immunol. 5:136-148.
24. Lorenzo, M. E., J. U. Jung, and H. L. Ploegh. 2002. Kaposi's sarcoma-associated herpesvirus K3 utilizes the ubiquitin-proteasome system in routing class major histocompatibility complexes to late endocytic compartments. J. Virol. 76:5522-5531.
25. Ma, H., J. E. Croudace, D. A. Lammas, and R. C. May. 2006. Expulsion of live pathogenic yeast by macrophages. Curr. Biol. 16:2156-2160.
26. Miranti, C. K. 2009. Controlling cell surface dynamics and signaling: how CD82/KAI1 suppresses metastasis. Cell Signal. 21:196-211.
27. Mostoslavsky, G., et al. 2005. Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal in vitro manipulation. Mol. Ther. 11:932-940.
28. Peter, G. P. 2006. Invasive candidiasis. Infect. Dis. Clin. N. Am. 20:485-506.
29. Poloso, N. J., L. K. Denzin, and P. A. Roche. 2006. CDw78 defines MHC class II-peptide complexes that require II chain-dependent lysosomal trafficking, not localization to a specific tetraspanin membrane microdomain. J. Immunol. 177:5451-5458.
30. Pukkila-Worley, R., and E. Mylonakis. 2008. Epidemiology and management of cryptococcal meningitis: developments and challenges. Exp. Opin. Pharmacother. 9:551-560.
31. Schorey, J. S., and S. Bhatnagar. 2008. Exosome function: from tumor immunology to pathogen biology. Traffic 9:871-881. (Pubitemid 351639493)
32. Singh, N., F. Dromer, J. Perfect, and O. Lortholary. 2008. Immunocompromised hosts: cryptococcosis in solid organ transplant recipients: current state of the science. Clin. Infect. Dis. 47:1321-1327.
33. Tarrant, J. M., L. Robb, A. B. van Spriel, and M. D. Wright. 2003. Tetraspanins: molecular organisers of the leukocyte surface. Trends Immunol. 24:610-617.
34. Todd, S. C., S. G. Lipps, L. Crisa, D. R. Salomon, and C. D. Tsoukas. 1996. CD81 expressed on human thymocytes mediates integrin activation and interleukin 2-dependent proliferation. J. Exp. Med. 184:2055-2060.
35. Torchinsky, M. B., J. Garaude, A. P. Martin, and J. M. Blander. 2009. Innate immune recognition of infected apoptotic cells directs TH17 cell differentiation. Nature 458:78-82.
36. Underhill, D. M., et al. 1999. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401:811-815.
37. Vyas, J. M., et al. 2007. Tubulation of class II MHC compartments is microtubule dependent and involves multiple endolysosomal membrane proteins in primary dendritic cells. J. Immunol. 178:7199-7210. (Pubitemid 46847446)
38. Vyas, J. M., A. G. Van der Veen, and H. L. Ploegh. 2008. The known unknowns of antigen processing and presentation. Nat. Rev. Immunol. 8:607-618.
39. West, M. A., et al. 2008. TLR ligand-induced podosome disassembly in dendritic cells is ADAM17 dependent. J. Cell Biol. 182:993-1005.
40. Wheeler, R. T., and G. R. Fink. 2006. A drug-sensitive genetic network masks fungi from the immune system. PLoS Pathog. 2:e35.
41. Wheeler, R. T., D. Kombe, S. D. Agarwala, and G. R. Fink. 2008. Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment. PLoS Pathog. 4:e1000227.
42. Wozniak, K. L., and S. M. Levitz. 2008. Cryptococcus neoformans enters the endolysosomal pathway of dendritic cells and is killed by lysosomal components. Infect. Immun. 76:4764-4771.
43. Wozniak, K. L., J. M. Vyas, and S. M. Levitz. 2006. In vivo role of dendritic cells in a murine model of pulmonary cryptococcosis. Infect. Immun. 74:3817-3824.
44. Xu, C., et al. 2009. CD82 endocytosis and cholesterol-dependent reorganization of tetraspanin webs and lipid rafts. FASEB J. 23:3273-3288.
45. Yauch, L. E., J. S. Lam, and S. M. Levitz. 2006. Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan. PLoS Pathog. 2:e120.
46. Zitvogel, L., et al. 1998. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 4:594-600.